Allarity Therapeutics Inc... (ALLR)
0.85
-0.08 (-8.41%)
At close: Mar 18, 2025, 3:59 PM
0.87
1.77%
After-hours: Mar 18, 2025, 07:59 PM EDT
Allarity Therapeutics Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Revenue | n/a | n/a | n/a | n/a | 120K | 1.46M | 1.46M | 143.28K | 362.29K | 9.97K | n/a |
| Cost of Revenue | 37K | 120K | 106K | 86K | n/a | 5.08M | 2.22M | n/a | n/a | 55.83K | 62.94K |
| Gross Profit | -37K | -120K | -106K | -86K | 120K | -3.62M | -761.5K | 143.28K | 362.29K | -45.85K | -62.94K |
| Operating Income | -17.93M | -34.46M | -26.56M | -9.23M | -17.61M | -4.98M | -3.84M | -4.49M | -1.4M | -68.66K | -81.19K |
| Interest Income | 22K | 30K | n/a | n/a | 7K | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -12.62M | -17.58M | -26.52M | -7.23M | -18.98M | -3.46M | -4.99M | -4.45M | -1.53M | -68.66K | -81.19K |
| Net Income | -11.9M | -16.06M | -26.65M | -5.07M | -14.4M | -2.29M | -4.9M | -3.68M | -1.15M | -68.66K | -81.19K |
| Selling & General & Admin | 10.03M | 9.96M | 12.36M | 4.1M | 3.87M | 1.28M | 3.07M | 272.39K | 89.15K | n/a | n/a |
| Research & Development | 7.87M | 6.93M | 14.2M | 5.13M | 6.37M | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Expenses | n/a | n/a | -474K | -681K | n/a | 84.39K | 8.7K | 4.36M | 1.67M | 22.81K | 18.24K |
| Operating Expenses | 17.89M | 16.89M | 26.56M | 9.23M | 10.24M | 1.36M | 3.08M | 4.63M | 1.76M | 22.81K | 18.24K |
| Interest Expense | 498K | 223K | 499K | 227K | 3.31M | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 17.93M | 16.89M | 26.56M | 9.23M | 10.24M | 6.44M | 5.3M | 4.63M | 1.76M | 78.64K | 81.19K |
| Income Tax | -717K | -1.52M | 133K | -2.16M | -4.58M | 1.07M | 95.09K | 766.89K | 380.16K | n/a | n/a |
| Shares Outstanding (Basic) | 1.99B | 11.34 | 7.57 | 3.89 | 3.89 | n/a | n/a | n/a | n/a | 1.17M | n/a |
| Shares Outstanding (Diluted) | 1.99B | 11.34 | 7.57 | 3.89 | 3.89 | n/a | n/a | n/a | n/a | 1.17M | n/a |
| EPS (Basic) | -0.01 | -1.86M | -3.52M | -1.7M | -189.61K | n/a | n/a | n/a | n/a | -0.06 | n/a |
| EPS (Diluted) | -0.01 | -1.86M | -3.52M | -1.7M | -189.61K | n/a | n/a | n/a | n/a | -0.06 | n/a |
| EBITDA | -12.08M | -17.24M | -25.91M | -6.01M | -15.58M | -4.9M | -3.83M | -4.21M | -1.13M | -45.85K | -0.05 |
| Depreciation & Amortization | 37K | 120K | 106K | 86K | 85K | 32.53K | 8.7K | 278.21K | 265.22K | 22.81K | 81.19K |